Trial Profile
Early Prostate Cancer program
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2007
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- Acronyms EPC
- Sponsors AstraZeneca
- 21 Feb 2007 New trial record.